Section 2: Parallel Runs and Cutover Techniques
A deep dive into the strategic decision of how to “flip the switch,” balancing risk, resources, and the relentless demands of patient care.
Parallel Runs and Cutover Techniques
Exploring the different strategies for “flipping the switch.”
16.2.1 The “Why”: The Most Important Clinical Decision of the Project
In your clinical practice, you constantly make strategic decisions based on a risk-benefit analysis. Do you recommend a high-potency statin with a greater risk of myalgia for a patient with established cardiovascular disease, or a lower-potency agent? The answer depends on the patient’s specific risk factors, comorbidities, and the clinical goal. The choice of a go-live strategy is the project management equivalent of this complex clinical judgment. There is no single “right” answer, only the “right” answer for a specific project, a specific organization, and a specific tolerance for risk.
Choosing how to transition from an old system to a new one is the single most consequential decision in determining the character and outcome of your implementation. It dictates the budget, the timeline, the strain on your clinical and technical resources, and, most importantly, the nature and magnitude of the potential risks to patient safety and hospital operations. Each potential path—the daring leap of a direct cutover, the methodical march of a phased rollout, or the resource-intensive safety of a parallel run—carries a profoundly different profile of “therapeutic benefits” and “adverse effects.”
Your role as a pharmacy informaticist is to be the expert pharmacologist of these strategies. You must be able to articulate not just what each strategy is, but what it feels like to live through one in the pharmacy. You must be able to advise leadership on the specific medication-use risks inherent in each approach and advocate for the strategy that best protects the integrity of the medication process. This section will provide you with the deep knowledge to dissect each methodology, enabling you to make an informed, defensible recommendation that aligns the project’s execution with the organization’s core mission of patient safety.
Retail Pharmacist Analogy: The Pharmacy Remodel Strategy
Imagine your pharmacy is undergoing a complete renovation: new shelving, new counters, new robots, and a new pharmacy management system. The corporate office has given you, the pharmacy manager, the authority to choose how the renovation will happen. This is your choice of cutover strategy.
Strategy 1: The Direct Cutover (“Big Bang”)
You decide to close the pharmacy entirely from Friday at 9 PM to Monday at 9 AM. A massive construction crew descends, tearing out everything old and installing everything new in a whirlwind 60-hour blitz.
The Good: It’s incredibly fast. The pain is intense but short. On Monday, everyone walks into a brand-new, fully functional pharmacy. There’s no confusion about which counter or computer to use.
The Bad: The risk is astronomical. If the new robot isn’t calibrated by Monday morning, no prescriptions get filled. If the new computer system fails to boot, you can’t serve a single patient. A failure is not a small problem; it’s a complete shutdown of operations.
Strategy 2: The Phased Rollout
You decide to remodel the pharmacy section by section over two months, while staying open. In week one, the crew remodels the OTC aisles overnight. In week two, they replace the drop-off and pickup counters. In week three, they install the new computer system, but only for the drop-off station. Finally, in week eight, they replace the main dispensing benches and the robot.
The Good: The risk at any one time is much lower. If the new OTC shelving is delayed, it doesn’t stop you from filling scripts. The team gets used to the changes gradually.
The Bad: It’s a long, drawn-out process. For two months, your pharmacy is a chaotic construction zone. Staff have to work in a confusing “hybrid” mode: they use the new computer for intake but the old computer for verification. This constant switching is inefficient and a recipe for errors.
Strategy 3: The Parallel Run
The landlord offers you the empty store next door. You decide to build an entire, perfect, duplicate pharmacy in that space while your old pharmacy continues to operate as usual. For the entire month of November, every prescription that comes in is filled twice: once by a team in the old pharmacy and once by a team in the new pharmacy. At the end of every day, you compare every single filled prescription to ensure they match perfectly. After 30 days of perfect matches, you simply close the old pharmacy and direct all patients to the new one.
The Good: This is the safest possible method. You have 100% verified that the new pharmacy works perfectly before a single patient is impacted. A rollback is as simple as locking the door to the new space.
The Bad: The cost and effort are astronomical. You have to pay double the staff for a month to do double the work. It’s exhausting, expensive, and generates a mountain of paperwork to reconcile the two operations.
16.2.2 The Direct Cutover (“Big Bang”): The All-In Approach
The Direct Cutover, often called the “Big Bang” approach, is the most straightforward and, simultaneously, the most audacious of all implementation strategies. The concept is simple: at a specific, pre-determined moment, the legacy system is turned off, and the new system is turned on. There is no overlap, no coexistence. All users, all departments, and all workflows move to the new system at the exact same time. It is a single, decisive, and irreversible leap from the old world to the new.
This strategy is akin to ripping off a bandage. The process is painful, but the pain is concentrated into a very short period—typically a single weekend. The go-live event itself is a period of intense, focused activity, followed by a period of hypercare support as the organization adjusts to the new reality. While the risk is immense, the primary benefit is the elimination of the complexity, cost, and confusion of maintaining and interfacing between old and new systems.
Visualizing the Direct Cutover
Legacy System Operations
All users on old system. Business as usual.
New System Live
All users on new system. The old system is OFF.
Masterclass Table: In-Depth Analysis of the Direct Cutover Strategy
| Aspect | Detailed Breakdown & Analysis |
|---|---|
| Benefits |
|
| Risks & Drawbacks |
|
| When It’s the Right Choice |
|
| The Pharmacist’s Critical Role & Focus |
For a direct cutover of a medication-use system, the pharmacy informatics team is the absolute center of the storm. Your focus must be on:
|
16.2.3 The Phased Rollout: A Strategy of Controlled Deployment
The Phased Rollout is a strategic middle ground between the all-or-nothing risk of a direct cutover and the exhaustive effort of a parallel run. The core principle is to break a large, complex implementation into smaller, more manageable pieces. The deployment occurs sequentially over an extended period, allowing the organization to digest the change in controlled increments. This approach is fundamentally about managing and containing risk.
The “phases” can be defined in several ways, each with its own strategic advantages and challenges:
- Phasing by Module/Functionality: The most common approach for large EHRs. For example, Phase 1 might be the core registration and billing systems. Phase 2 would be CPOE and clinical documentation. Phase 3 would be the pharmacy system and eMAR.
- Phasing by Location/Department (“Pilot” approach): The full system is deployed, but only to a limited area of the hospital. For example, the new CPOE and eMAR system might go live first in a single medical-surgical unit. This unit becomes a real-world pilot. Once the system is stable and the workflows are optimized there, it is then rolled out to other units, floor by floor.
- Phasing by Patient Population: Less common, but can be used in specialized hospitals. For example, a children’s hospital might roll out new pediatric-specific order sets and workflows first, before tackling the adult population in a separate phase.
Regardless of the method, the core idea is the same: learn and stabilize in a controlled environment before expanding.
Visualizing the Phased Rollout (by Location)
ICU Go-Live
Phase 1
Rest of Hospital on Legacy System
ICU & Med/Surg Go-Live
Phase 2
ED & OR on Legacy System
Full Hospital Go-Live Complete
Final Phase
Masterclass Table: In-Depth Analysis of the Phased Rollout Strategy
| Aspect | Detailed Breakdown & Analysis |
|---|---|
| Benefits |
|
| Risks & Drawbacks |
|
| When It’s the Right Choice |
|
| The Pharmacist’s Critical Role & Focus |
In a phased rollout, the pharmacy informaticist becomes a master of managing complexity and communication. Your focus is on:
|
The Patient Transfer: The Phased Rollout’s Greatest Weakness
The single most dangerous moment in a phased rollout is the transfer of a patient between a unit on the new system and a unit on the old system. The potential for lost orders, incorrect doses, and missed administrations is enormous. As an informaticist, you must design robust manual and electronic processes to mitigate this risk. This is a non-negotiable safety requirement and often the most challenging part of a phased implementation.
16.2.4 The Parallel Run: The Ultimate Safety Net
The Parallel Run is the most risk-averse, resource-intensive, and least common of the cutover strategies. The methodology is one of complete duplication: for a defined period (e.g., one week, one month), the organization continues to run its legacy system as the “source of truth” while simultaneously performing the exact same work in the new system. It is, in essence, doing every job twice.
The purpose of this dual processing is to perform a real-time, real-world validation of the new system’s outputs against the known, trusted outputs of the legacy system. At the end of each day or each shift, dedicated teams perform a meticulous reconciliation to compare the results from the two systems. If the new system’s output (e.g., a patient bill, a pharmacy cart-fill report, a lab result) perfectly matches the legacy system’s output, confidence in the new system grows. If there are discrepancies, they are investigated and resolved immediately. The go-live “cutover” only occurs after a pre-defined period of perfect or near-perfect matching, at which point the legacy system is finally turned off.
Visualizing the Parallel Run
Parallel Operations Period (e.g., 30 Days)
Legacy System
Source of Truth. All work is performed here.
New System
Validation Mode. All work is duplicated here.
Daily Reconciliation
Outputs from both systems are compared. Discrepancies are resolved.
New System Live
After successful parallel period, the legacy system is turned OFF.
Masterclass Table: In-Depth Analysis of the Parallel Run Strategy
| Aspect | Detailed Breakdown & Analysis |
|---|---|
| Benefits |
|
| Risks & Drawbacks |
|
| When It’s the Right Choice |
|
| The Pharmacist’s Critical Role & Focus |
In a parallel run, the pharmacy informaticist is the operational commander of the validation process. Your job is to design and execute the reconciliation. Your focus is on:
|
16.2.5 The Final Verdict: A Clinical Decision Framework
The selection of a cutover strategy is not a purely technical or financial decision; it is a clinical one, with profound implications for patient safety and operations. As the informatics pharmacist, you are uniquely positioned to weigh the technical constraints against the clinical realities. Your recommendation should be based on a formal analysis of the project’s characteristics and the organization’s culture. The following matrix provides a framework for guiding this critical decision.
Masterclass Decision Matrix: Selecting Your Go-Live Strategy
| Decision Factor | Favors Direct Cutover (“Big Bang”) | Favors Phased Rollout | Favors Parallel Run |
|---|---|---|---|
| Risk Tolerance | High tolerance for short-term, high-impact disruption. The organization has a “fail-fast, fix-fast” culture. | Low tolerance for large-scale disruption. The organization prefers incremental, predictable change and is highly risk-averse. | Extremely low to zero tolerance for any data or calculation errors in system output. Safety and accuracy override all other concerns. |
| System Interdependency | System components are tightly coupled and cannot function independently. A monolithic, all-or-nothing architecture. | The system is modular. Functionality or locations can be separated with manageable temporary interfaces. | The system’s primary function is to produce critical outputs (e.g., bills, labels, reports) that can be directly compared to a legacy equivalent. |
| Budget & Resources | The budget is constrained, and the primary goal is to minimize the project timeline and avoid the cost of temporary interfaces and dual system maintenance. | The budget can accommodate a longer project timeline and the development of temporary interfaces. | The budget is substantial and can absorb significant overtime and/or temporary staffing costs to ensure 100% validation. |
| Scale of Change | The change is relatively small, or the organization is small and agile enough to manage an organization-wide change simultaneously. | The change is massive, impacting a large, complex organization (e.g., a multi-hospital system) where a single event would be unmanageable. | The scale of change is less important than the criticality of the outputs. Even a small system may warrant a parallel run if its outputs are vital. |
| Data Complexity | Data migration is straightforward, and pre-go-live validation can provide a very high degree of confidence in its accuracy. | Data is complex and resides in multiple systems. A phased approach allows for more focused data migration efforts for each component. | Data integrity is the single most important factor. The only way to be 100% certain is to validate with live, parallel transaction processing. |
Your Final Recommendation
Ultimately, your role is to be the voice of reason and safety. While project managers may focus on the timeline and executives on the budget, you must constantly bring the conversation back to the patient. You must translate the abstract concepts of “risk” and “disruption” into concrete clinical scenarios.
When advocating for your chosen strategy, frame it in the language of pharmacy:
“While a Direct Cutover is the fastest approach, it carries a risk profile similar to starting a patient on a high-risk anticoagulant without a baseline INR. The potential for a catastrophic event is significant. I can only endorse this if our pre-launch ‘lab work’—our validation testing—is absolutely perfect.”
“A Phased Rollout is like titrating a medication. We start with a low dose (the pilot unit), monitor for adverse effects, and only increase the dose (roll out to more units) when we’ve confirmed the patient (the organization) is tolerating it well. The primary side effect we must manage is the confusion of the ‘hybrid state’.”
“A Parallel Run is our version of a clinical trial. We are proving bioequivalence, demonstrating that our new generic (the new system) produces the exact same clinical outcome as the brand name drug (the legacy system) before we make the switch. It is expensive and labor-intensive, but it provides the highest possible guarantee of safety and efficacy.”